Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Roche Holding AG
  6. News
  7. Summary
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Press Release : Roche's Gazyvaro shorter 90-minute -2-

10/14/2021 | 01:00am EST

Phone: +41 61 688 8888 / e-mail: https://www.globenewswire.com/Tracker?data=p_AdIzYMIcli6PzwSf9n2a3JTdXej-9Bbhh7fLJRL82rxP7sAwtfq1rdXqURRFacZnLaTy2GYJfGmdhc8m-n3q735QE0klNcFULR8W4kKAPxJB1sQVZ-u6yrGjO0n2lB media.relations@roche.com

 
Dr. Nicolas Dunant          Patrick Barth 
 Phone: +41 61 687 05 17     Phone: +41 61 688 44 86 
Dr. Barbara von Schnurbein  Karsten Kleine 
 Phone: +41 61 687 89 67     Phone: +41 61 682 28 31 
Nina Mählitz           Nathalie Meetz 
 Phone: +41 79 327 54 74     Phone: +41 61 687 43 05 
Sileia Urech 
 Phone: +41 79 935 81 48 
 
 
Roche Investor Relations 
Dr. Karl Mahler                               Jon Kaspar Bayard 
 Phone: +41 61 68-78503                        Phone: +41 61 68-83894 
 e-mail: mailto:karl.mahler@roche.com          e-mail: mailto:jon_kaspar.bayard@roche.com 
 karl.mahler@roche.com                         jon_kaspar.bayard@roche.com 
--------------------------------------------  ------------------------------------------- 
Dr. Sabine Borngräber                    Dr. Bruno Eschli 
 Phone: +41 61 68-88027                        Phone: +41 61 68-75284 
 e-mail: mailto:sabine.borngraeber@roche.com   e-mail: mailto:bruno.eschli@roche.com 
 sabine.borngraeber@roche.com                  bruno.eschli@roche.com 
--------------------------------------------  ------------------------------------------- 
Dr. Birgit Masjost                            Dr. Gerard Tobin 
 Phone: +41 61 68-84814                        Phone: +41 61 68-72942 
 e-mail: mailto:birgit.masjost@roche.com       e-mail: mailto:gerard.tobin@roche.com 
 birgit.masjost@roche.com                      gerard.tobin@roche.com 
--------------------------------------------  ------------------------------------------- 
 
Investor Relations North America 
Loren Kalm 
 Phone: +1 650 225 3217 
 e-mail: mailto:kalm.loren@gene.com 
 kalm.loren@gene.com 
-------------------------------------------- 
 

Attachment

   -- 14102021_MR_Gazyva 
      https://ml-eu.globenewswire.com/Resource/Download/cc8f6d6e-4200-451c-96fc-26ad6df6c9c3 
 
 
 

(END) Dow Jones Newswires

October 14, 2021 01:00 ET (05:00 GMT)

All news about ROCHE HOLDING AG
09:57aJazz Pharmaceuticals Announces First Patient Enrolled in IMforte Phase 3 Trial Evaluati..
AQ
06:38aAlphaValue/Baader Europe Lowers Price Target on Roche, Maintains Add Recommendation
MT
01:17aRoche Closes Biotechnology Group TIB Molbiol Acquisition
MT
01:01aRoche completes purchase agreement with long-term partner TIB Molbiol to expand PCR-tes..
AQ
11/30Roche Uses Amazon Web Services For Most Cloud Needs
MT
11/29Thermo Fisher says its COVID-19 tests accurately detects Omicron variant
RE
11/26Chugai Pharmaceutical Co. - Anti Cancer Agent Herceptin Approved for Additional Indicat..
AQ
11/26Roche Shareholders Approve Deal to Buy Back Novartis' Stake in Swiss Drugmaker
MT
11/26Roche shareholders approve deal to buy Novartis's $20.7 billion stake
RE
11/26Roche Shareholders OK $21 Billion Repurchase Deal With Novartis
MT
More news
Analyst Recommendations on ROCHE HOLDING AG
More recommendations
Financials
Sales 2021 62 134 M 67 601 M 67 601 M
Net income 2021 15 273 M 16 617 M 16 617 M
Net cash 2021 4 368 M 4 752 M 4 752 M
P/E ratio 2021 19,6x
Yield 2021 2,59%
Capitalization 311 B 338 B 338 B
EV / Sales 2021 4,93x
EV / Sales 2022 4,82x
Nbr of Employees 101 465
Free-Float 83,5%
Chart ROCHE HOLDING AG
Duration : Period :
Roche Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROCHE HOLDING AG
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 359,65 CHF
Average target price 388,44 CHF
Spread / Average Target 8,01%
EPS Revisions
Managers and Directors
Severin Schwan Chief Executive Officer & Executive Director
Alan Hippe Chief Financial & Information Technology Officer
Christoph Franz Chairman
Urs Jaisli Chief Compliance Officer
AndrÚ S. Hoffmann Vice Chairman
Sector and Competitors
1st jan.Capi. (M$)
ROCHE HOLDING AG16.39%337 091
JOHNSON & JOHNSON-0.92%410 501
PFIZER, INC.45.97%301 579
NOVO NORDISK A/S65.17%243 741
ELI LILLY AND COMPANY46.91%224 871
ABBVIE INC.7.59%203 801